Target intelligence / Profile preview

Neisseria meningitidis capsular polysaccharide group Y

Molecular classification
Polysaccharide, Capsular Polysaccharide
01

Overview

The Neisseria meningitidis group Y capsular polysaccharide is a linear heteropolymer composed primarily of alternating D-glucose and N-acetylneuraminic acid residues with specific glycosidic linkages. Its synthesis involves dedicated genes within the cps locus on the bacterial chromosome. This structure not only defines serogroup specificity but also underpins both pathogenesis—by protecting bacteria from host defenses—and prevention strategies through its inclusion in effective conjugate vaccines against invasive disease caused by this organism.

Other names
Group Y capsular polysaccharideSerogroup Y capsuleN. meningitidis serogroup Y capsular polysaccharide
02

Mechanism of action

Vaccines induce antibody production that opsonizes bacteria for phagocytosis and complement-mediated lysis.

03

Biological functions

Immune evasionVirulence factorProtection from complement-mediated killingProtection from phagocytosis
04

Disease associations

Invasive meningococcal diseaseMeningitisSepticemia
05

Safety considerations

Capsule switching may reduce vaccine effectiveness.Limited protection against strains expressing different capsular serogroups.
06

Interacting drugs

Quadrivalent conjugate vaccines (A, C, W, Y)

1 more in the full profile.

Beyond the preview

Go deeper on Neisseria meningitidis capsular polysaccharide group Y.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis capsular polysaccharide group Y.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call